1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Zemaira lost patients

Discussion in 'CSL Behring' started by Just asking, Aug 23, 2018 at 9:21 PM.

Tags: Add Tags
  1. Just asking

    Just asking Guest

    WOW lost patients due to no product. How many do you think switched?

  2. I hope manufacturing is able to get this cleared up sooner rather than later. The longer this goes on, the more difficult it will be to rebuild our relationships.
  3. anonymous

    anonymous Guest

    Management doesn't give a d*mn about Zemaira. Milk that cow until it's dead!!!
  4. anonymous

    anonymous Guest

    currently < 127 still on product. Should be back soon. Price reduction may be needed to get customers back.